ARTICLE | Company News
Bioxel deal
January 20, 2003 8:00 AM UTC
BIP and an undisclosed Canadian company partnered to produce a paclitaxel-derivative formulation to treat cancer and other diseases. BIP retains ownership of the taxane derivatives and the rights to p...